IV Accelerator Cohort II

About

A 10-week accelerator run by an AI-healthcare-focused venture fund gives pre-seed and seed companies incorporated in the US or Canada a $25,000 check at acceptance, weekly investor-led sessions and a New York Demo Day, with Cohort II applications due 6 November 2026.

Benefits

• 💵$25,000 investment
  Each accepted company receives a $25,000 investment from Intelligence Ventures Fund I at acceptance, described as coming with no strings beyond standard accelerator terms.
• 🧑‍🏫 Investor-mentor sessions
  Sessions are led by the fund's LPs — active investors and operators in AI healthcare — plus clinicians and hospital-system operators.
• 🌐Investor network
  Participants gain access to 500+ investor relationships built over three years, spanning VCs, family offices and angels.
• 🎤Demo Day in New York
  At the end of week 10, companies present and network in front of an audience curated for their stage and verticals.
• 🎁Founder perks
  Discounted access to vetted service providers and partner perks that the organizer describes as still growing.
• 🏆Possible follow-on investment
  The organizer has stated it plans to invest an additional $25,000 in top performers after Demo Day; this is conditional and not guaranteed.

Eligibility Criteria

• Applicants must be building an AI healthcare product in which AI is core to the product rather than a wrapper.
• Companies must be at pre-seed or seed stage.
• Companies must have a pre-money valuation of less than $10M.
• The product must fall within one of four verticals: biotech and pharma tools (excluding therapeutics), medical devices, diagnostics, or healthcare SaaS.
• Therapeutics companies are not funded.
• Companies must be incorporated in the United States or Canada.
• The company must have a full-time founding team.
• Selected companies must be able to attend a 3-day kickoff (location to be determined) and Demo Day in New York.

Participation Commitments

• Applications for Cohort II close on 6 November 2026.
• Interviews take place in November 2026.
• The program runs 10 weeks, with the official page listing a cohort start in Spring 2027 and a January 2027 kickoff.
• The program opens with a 3-day in-person kickoff, with the location listed as to be determined.
• Weeks 2–9 run virtually with two 3-hour sessions per week, described as roughly four required hours weekly.
• Demo Day takes place in New York in week 10.
• Cohort size is 10 companies.

Target Sector

Healthcare & Life Sciences

Target Location

Eligible companies must be incorporated in the United States or Canada.